Custom exome panel revealed new mutations in MAPK14 and novel mutation in RUNX2 gene in patients with PCOS
Abstract Polycystic ovary syndrome (PCOS) is the most common endocrinopathy and is both phenotypically and genotypically heterogeneous. A large number of genetic variants have been found in different genes, so far. Based on the literature, we identified 7 genes and aimed to find new causative varian...
Saved in:
Main Authors: | Yunus Arikan, Taylan Onat |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-81969-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Use of Yoga in the Treatment of PCOS
by: Agnieszka Przesor Przezor, et al.
Published: (2025-01-01) -
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism
by: Zhigang Huang, et al.
Published: (2025-02-01) -
PRDM16 Enhances Osteoblastogenic RUNX2 via Canonical WNT10b/β-CATENIN Pathway in Testosterone-Treated Hypogonadal Men
by: Siresha Bathina, et al.
Published: (2025-01-01) -
Amentoflavone from Selaginella bryopteris leaf extracts modulate MAPK signaling - Molecular modeling study for therapeutic target analysis
by: Praveen Mallari, et al.
Published: (2025-05-01) -
Transcription factor RUNX1 regulates coagulation factor XIII-A (F13A1): decreased platelet-megakaryocyte F13A1 expression and clot contraction in RUNX1 haplodeficiency
by: Fabiola Del Carpio-Cano, et al.
Published: (2025-01-01)